Status: Completed,
Condition Summary: Dry Eye Disease
Acucela to Present at ARVO 2016 Annual Meeting’s Education Courses in Seattle
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today that Dr. Ryo Kubota, MD, PhD, and Chairman, President and CEO of Acucela will present at the Education Courses associated with The Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting being held May 1-5, 2016
Uncategorized
Bilateral, contralateral multifocal IOLs yield similar intermediate, distance visual acuity
Bilateral implantation of a multifocal IOL was non-inferior to contralateral implantation of different multifocal IOLs in terms of intermediate and distance visual acuity, according to a study. However, bilateral implantation did not yield comparable near vision.“These results suggest that contralateral implantation might have a higher likelihood than bilateral implantation of patients attaining spectacle independence over a wide range of distances,” the study authors said.
Office-Based Cataract Surgery Safe and Effective
In-office cataract surgery provided patient outcomes comparable to hospital-based procedures while minimizing direct medical costs, a large, population-based study has found. Medscape Medical News
Bacteria-derived gut metabolites can affect brain’s myelin content and induce depression-like symptoms
Specific combinations of gut bacteria produce substances that affect myelin content and cause social avoidance behaviors in mice, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the medical journal e…
Is Weight Gain to Blame for This Man’s Blurred Vision?
A 42-year-old man presents with blurred vision of gradual onset in his left eye. A closer look at his history may provide the clues to the diagnosis. Medscape Ophthalmology